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Abstract
Background: Asclepias curassavica Linn. is a traditional medicinal plant used by tribal people in the western ghats, 
India, to treat piles, gonorrhoea, roundworm infestation and abdominal tumours. We have determined the protective 
effect of β-sitosterol isolated from A. curassavica in colon cancer, using in vitro and in vivo models.
Methods: The active molecule was isolated, based upon bioassay guided fractionation, and identified as β-sitosterol 
on spectral evidence. The ability to induce apoptosis was determined by its in vitro antiradical activity, cytotoxic studies 
using human colon adenocarcinoma and normal monkey kidney cell lines, and the expression of β-catenin and 
proliferating cell nuclear antigen (PCNA) in human colon cancer cell lines (COLO 320 DM). The chemopreventive 
potential of β-sitosterol in colon carcinogenesis was assessed by injecting 1,2-dimethylhydrazine (DMH, 20 mg/kg b.w.) 
into male Wistar rats and supplementing this with β-sitosterol throughout the experimental period of 16 weeks at 5, 10, 
and 20 mg/kg b.w.
Results: β-sitosterol induced significant dose-dependent growth inhibition of COLO 320 DM cells (IC50 266.2 μM), 
induced apoptosis by scavenging reactive oxygen species, and suppressed the expression of β-catenin and PCNA 
antigens in human colon cancer cells. β-sitosterol supplementation reduced the number of aberrant crypt and crypt 
multiplicity in DMH-initiated rats in a dose-dependent manner with no toxic effects.
Conclusion: We found doses of 10-20 mg/kg b.w. β-sitosterol to be effective for future in vivo studies. β-sitosterol had 
chemopreventive potential by virtue of its radical quenching ability in vitro, with minimal toxicity to normal cells. It also 
attenuated β-catenin and PCNA expression, making it a potential anticancer drug for colon carcinogenesis.
Background
Lung, breast and colon cancer are the 3 most common
cancers worldwide, with an increasing annual incidence
[1]. Scavenging reactive oxygen species (ROS) by antioxi-
dant activity is important in preventing potential damage
to cellular components, including DNA, proteins, and
lipids. Oxidative damage can cause major events, some-
times leading to carcinogenesis. Antioxidants have been
used to inhibit apoptosis because apoptosis appeared ini-
tially to be mediated by oxidative stress [2]. Several in
vitro and in vivo studies suggest that plant sterols can
protect against colon, prostate, and breast cancers in
developed countries [3]. Colon cancer is frequently a
pathological consequence of persistent oxidative stress,
leading to DNA damage and mutations in cancer-related
genes, cell cycle death and regeneration, where cellular
overexpression of β-catenin and proliferating cell nuclear
antigen (PCNA) are implicated [4]. Increase in the cyto-
plasmic pool of β-catenin is associated with cell prolifera-
tion, and resistance to apoptosis and carcinogenesis [5].
1,2-Dimethylhydrazine (DMH) induced colon carcino-
genesis in the rat is a widely used experimental model
among cancer chemoprevention studies. Aberrant crypt
foci (ACF) are putative preneoplastic lesions of colonic
neoplasia in rodents and humans. During the process of
colon carcinogenesis, ACF appear in the early stages and
subsequently develop into polyps, adenomas and eventu-
ally carcinomas [6]. The goal of cancer chemoprevention
is to retard, block or reverse the process of carcinogenesis
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through the use of natural or synthetic agents, including
antioxidants.  A. curassavica p o w d e r  i s  u s e d  t o  t r e a t
abdominal tumors in traditional Indian medicine. β-sitos-
terol and its glycosides, along with other compounds
such as oleanolic acid, uzarigenin, calactin, calotropin,
coroglaucigenin, calotropagenin and uzarin have been
isolated. The cytotoxic principle of A. curassavica proved
to be calotropin [7].
β-sitosterol isolated from various plants promotes
apoptosis by increasing FAS levels and caspase-8 activity
[8], phosphorylation of extracellular-signal regulating
kinase (ERK) and p38 mitogen-activated protein kinase
(MAPK) [9], inhibition of cancer cell proliferation - even
at low concentrations with no cytotoxic effect to noncan-
cerous cells [10], modulation of antioxidant enzyme levels
i n  p a t h o g e n e s i s  [ 1 1 ] ,  a r r e s t  o f  c e l l s  a t  G 2 / M  p h a s e  i n
prostate cancer cells [12], and decreasing free radical gen-
eration in vitro [13]. A large number of medicinal plants
and their purified constituents have beneficial therapeu-
tic potentials. In this context, our work aimed to broaden
the understanding of the anticancer potential of β-sitos-
terol in in vitro cancer model and DMH-induced experi-
mental colon carcinogenesis model, which could be
beneficial in anticancer therapy.
Methods
Chemicals
Dulbecco's modified Eagle's medium (DMEM), Rosewell
Park Memorial !nstitute 1640 medium (RPMI-1640), 2,2-
diphenyl-1-picrylhydrazyl (DPPH), 3-(4,5-dimethyl thi-
azol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT),
2',7'-dichlorofluorescein (DCF-DA), HOECHST 33258,
and 1,2-dimethylhydrazine (DMH) were purchased from
Sigma Chemical Company. Fetal bovine serum (FBS),
phosphate buffered saline, Trypsin-EDTA - 0.25%, Anti-
biotic-antimycotic solution from Invitrogen (USA).
AnnexinV-FITC antibody and propidium iodide kit were
purchased from Biosource, Camarillo, CA USA. The
commercial rat pellet diet used was purchased from Hin-
dustan Lever Ltd, Mumbai, India. All other chemicals,
including solvents, were of high purity analytical grade
marketed by HiMedia chemicals, Mumbai, India.
Isolation of β-sitosterol from A. curassavica
A. curassavica leaves were collected from Kodhaiyar,
Western Ghats, Tamil Nadu and carefully identified by
Dr. Ayyanar, a taxonomist at the Department of Botany,
Loyola College, Chennai, India. One kilogram of shade
dried leaves was placed in an aspirator; 3 L hexane were
added and the mixture shaken occasionally for 48 h.
Extracts were filtered through Whatman filter paper no. 2
on a Buchner funnel and the solvent removed under
reduced pressure in a rotary evaporator at 40°C. The
extracts were placed in preweighed flasks before drying.
The remaining plant residue was extracted sequentially
with ethyl acetate and methanol. The extracts obtained
were dissolved in dimethyl sulphoxide (DMSO) and used
as a stock solution. This stock solution was filter-steril-
ized (0.22 μm) prior to experimental use.
Active ethyl acetate extract (20 g) was subjected to col-
umn chromatography and eluted with hexane, followed
by combinations of hexane:ethyl acetate ranging from
95:5 to 0:100. The eluted fractions were combined to give
major fractions by comparing the Rf values of the col-
lected fractions when run on TLC F254 plates in similar
solvent systems. Based upon the TLC pattern, the frac-
tions were pooled to give 17 major fractions. The col-
lected fractions were screened for their anticancer
property, based on bioassay guided fractionation. F12 was
identified as active. White crystals deposited on the walls
after further purification of F12. These crystals produced
a single spot on TLC, confirmed to be a single compound,
which was subjected to IR, MASS, and NMR analysis for
structure elucidation. The physical and chemical data of
F12 corresponded to that of β-sitosterol. The crude, frac-
tions and the isolated compound were screened for cyto-
toxicity using human colon cancer cell line - COLO 320
DM, human gastric cancer - AGS, human breast cancer -
MCF-7 and human liver cancer - A549, and a normal
monkey kidney - VERO. The extracts, fractions and β-
sitosterol showed promising antiproliferative activity in
COLO 320 DM cells (preliminary data - not shown).
In vitro antioxidant activity
DPPH free radical scavenging assays were carried by the
method of Blois [14]. Antioxidants react with stable free
radical DPPH and are converted into 1,1-diphenyl-2-pic-
ryl-hydrazine. The ability to scavenge DPPH was mea-
sured by the decrease in absorbance at 517 nm, using
ascorbic acid as a standard antioxidant for comparison.
Nitric oxide (NO) was generated from sodium nitropru-
side and measured by Griess' reaction as described by
Garrat [15].
Cell lines
Human COLO 320 DM and monkey VERO cell lines pur-
chased from the National Center for Cell Science (NCCS,
Pune) were cultured in 75-cm2 flasks containing DMEM
for VERO and RPMI-1640 for the COLO 320 DM line.
Both media were supplemented with 10% FBS, 10,000 U/
ml penicillin, 10 mg/ml streptomycin, and 25 μg/ml
ampotericin B. Cells were cultured as monolayers in cul-
ture flasks at 37°C at 95% humidity in 5% CO2 in air. After
reaching 80-90% confluence, cells were trypsinized and
subcultured. During the experiments, serum-containing
medium was replaced by serum-free medium containing
15, 30, 60, 120 and 240 μM/ml β-sitosterol dissolved inBaskar et al. BMC Complementary and Alternative Medicine 2010, 10:24
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DMSO and the stock maintained at -20°C. The final
working concentration of DMSO was <0.1%.
Antiproliferative activity
Survival of cells was assayed by the MTT method of Mos-
mann [16] after treatment with 15, 30, 60, 120 and 240
μM/ml of compound for 24 h. Optical density (OD) was
measured using a 96-well micro plate-reader (BIO-RAD,
model 680, USA) at 570 nm.
Flow cytometric analysis
Apoptosis was determined using FITC-labeled AnnexinV
antibody by flow cytometry [17]. The fraction of the cell
population in different quadrants was analyzed using
quadrant statistics. Cells in the lower right quadrant rep-
resented apoptosis, and those in the upper right quadrant
represented necrosis or post-apoptotic necrosis [18].
Assessment of ROS levels
COLO 320 DM cells were incubated with 5 μM DCF-DA
for 20 min and washed 3 times with PBS. Levels of intrac-
ellular ROS were subsequently determined by image
analysis of DCF-DA loaded cells with a confocal micro-
scope (excitation at 488 nm and emission at 525 nm).
DCF-DA is membrane permeable and interacts with
reactive oxygen species in living cells, emitting light in the
green wavelength.
DNA fragmentation
To confirm morphological changes in the nuclei, cells
were seeded in 16-mm cover slips placed in 6-well plates
at 2 × 106 cells. Cells were treated 1 day after seeding with
15, 60 and 120 μM β-sitosterol for 24 h. HOECHST
33258 solution was added (20 μg/mL), and the cells incu-
bated for 30 min before being examined by fluorescence
microscopy (Olympus, Tokyo, Japan).
Expression of PCNA and β catenin
Fifty μg protein of the total cell lysate was mixed with an
equal volume of 2× sample buffer (125 mM Tris-HCl (pH
6.8), 4% SDS, 20% glycerol, 10% β-mercaptoethanol and
0.004% bromophenol blue), boiled for 5 min at 95°C,
cooled, loaded on each lane of 8-15% polyacrylamide gels,
and separated by SDS-PAGE at room temperature. The
resolved proteins were electrophoretically transferred to
nitrocellulose membranes. The membranes were blocked
in 5% non-fat milk in Tris-buffered saline with 0.1%
Tween 20 for 1 h at room temperature, and probed with
β-catenin [mouse monoclonal antibody dilutioned
1:1000] (BD transduction laboratories, USA); PCNA
[mouse monoclonal antibody diluted 1:1000] (Santa Cruz
biotechnology, USA) primary antibodies overnight at
4°C. The blots were extensively washed with Tris-buff-
ered saline with 0.1% Tween 20 and incubated with
respective anti-mouse HRP labeled secondary antibody
at a dilution of 1:2000 for 1 h at room temperature. After
e x t e n s i v e  w a s h e s  i n  T B S - T ,  b a n d s  w e r e  v i s u a l i z e d  b y
treating the membranes with 3,3'-diaminobenzidine tet-
rahydrochloride. The membranes were photographed
and the bands quantified with image analysis software
(Imagej, NIH, USA). Densitometry data presented in the
bar graphs are the "fold change" compared with control in
each case.
Animals
Male albino Wistar rats aged 5 weeks obtained from Cen-
tral Animal House, Kings Institute, Chennai, Tamil Nadu,
were used. The animals were cared for in compliance
with the principles and guidelines of Ethical Committee
for Animal Care and institutional animal ethical commit-
tee, in accordance with the Indian National Law on Ani-
mal Care and Use (Reg. No. 833/a/2 004/CPC SEA). The
animals were housed 4 per polypropylene cage with a
wire-mesh top and a hygenic bed of husk in a specific
pathogen-free animal room under controlled conditions
of a 12 h light/12 h dark cycle with temperature of 24 ±
2°C and relative humidity of 50 ± 10% until the end of the
experimental period. The rats were held in quarantine for
1 week and had access to food and tap water ad libitum.
Commercial pellet diet containing 4.2% fat was powdered
and mixed with 15.8% peanut oil, making a total of 20%
fat. This modified diet was fed to all rats throughout the
16 week experimental period.
Administration of carcinogen
The experimental animals were divided into 6 groups.
Initial body weights of all animals in the protocol were
between 80-120 g. Animal weights were recorded once a
week throughout the experimental period, and prior to
sacrifice.
The animals in groups 3 - 6 received subcutaneous
injections of DMH at 20 mg/kg b.w. once a week for the
first 4 consecutive weeks. Prior to subcutaneous injec-
tion, DMH was dissolved in 1 mM EDTA; the pH was
adjusted to 6.5 with 1 mM NaOH to ensure the pH and
stability of the chemical, and used immediately after
preparation.
β-sitosterol treatment of the animals
Group 1 - Rats received modified pellet diet along with
intragastric intubation of 0.1% carboxymethyl cellulose
(CMC) (1.0 mL), throughout the experimental period.
Group 2 - Rats received modified pellet diet + 20 mg/kg
b.w. β-sitosterol suspended in 0.1% CMC (1.0 mL), p.o.,
everyday throughout the experimental period.
Group 3 - Rats were administered with 20 mg/kg b.w.
DMH (carcinogen) s.c. once a week for 4 consecutive
weeks and no further treatment for the next 12 weeks.Baskar et al. BMC Complementary and Alternative Medicine 2010, 10:24
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Group 4 - The animals were treated as in group 3 along
with β-sitosterol (5 mg/kg b.w., p.o.) supplemented
throughout the entire experimental period of 16 weeks.
Group 5 - The animals were treated as in group 3 along
with β-sitosterol (10 mg/kg b.w., p.o.) supplemented
throughout the entire experimental period of 16 weeks.
Group 6 - The animals were treated as in group 3 along
with β-sitosterol (20 mg/kg b.w., p.o.) supplemented
throughout the entire experimental period of 16 weeks.
At the end of the experiment, colons were processed to
assess ACF by the method of Bird [19]. The total number
of ACF/rat was calculated from the sum of all ACF . T o
determine crypt multiplicity, the number of aberrant
crypts in each focus was recorded.
Statistical analysis
The results of the cytotoxicity tests (n = 6) were calcu-
lated as the percentage growth inhibition relative to the
control. IC50 values for growth inhibition were derived
from a non-linear regression model (curvefit), based on
sigmoidal dose-response curve (variable), computed
using GraphPadPrism (Graphpad). Data are given as
mean ± S.E.M. The statistical significance was set at P <
0.05. Statistical evaluation involved one-way analysis of
variance (ANOVA) followed by Duncan's multiple range
test (DMRT).
Results
The purified compound isolated from A. curassavica was
identified as β-sitosterol based on Physiochemical evi-
dence (Figure 1) as by extraction method listed in "Mate-
rials and Methods". The total collected ethyl acetate
extract was 2.2 kg, and the yield of β-sitosterol 1.85 gm.
β-sitosterol had anti-radical activity, with an IC50 of 389.5
μM and 448.2 μM for DPPH and NO scavenging assays,
respectively (Figure 2A &2B). β-sitosterol was noticeably
inhibitory within 24 h at 30 μM and significantly more so
at 240 μM (P < 0.05; Figure 3A), with minimal toxicity in
non-cancerous cells (VERO). IC50 values were 266.2 μM
for COLO 320 cells and >1 mM for VERO cells.
Induction of apoptosis, and PCNA and β-catenin expression 
by β-sitosterol
A n  i n c r e a s e d  n u m b e r  o f  C O L O  3 2 0  D M  c e l l s  t r e a t e d
with 240 μM β-sitosterol stained with Annexin FITC+/
PI+, with a lower percentage of necrotic or propidium
iodide stained cells after 24 h incubation (Figure 3B). β-
sitosterol induced DNA fragmentation even at a 15 μM;
increased DNA fragmentation and DNA tailing also
ocurred in cancer cells treated with 120 μM β-sitosterol
(Figure 3C).
DCF fluorescence in COLO 320 DM cells indicates
enhanced free radical generation in living cells (Figure
4A). After treatment with β-sitosterol for 24 h, fluores-
cence clearly reduced (Figure 4D).
Colonic cell proliferation and β-catenin expression
were analyzed using human colon cancer (COLO 320
DM) cells treated with β-sitosterol for 24 h. β-sitosterol
administration significantly decreased β-catenin and
PCNA expression in COLO 320 DM cells in vitro (Figure
5).
Inhibition of ACF development by β-sitosterol
β-sitosterol supplementation per se did not induce aber-
rant crypt formation in colonic mucosa of non-DMH
treated rats. β-sitosterol treatment for 16 weeks signifi-
cantly also reduced the number of aberrant crypt and
crypt multiplicity in a dose-dependent manner in DMH-
treated rats (Table 1, Figure 6).
Discussion
Elevated oxidative stress can modify a number of cellular
targets and cause cell damage, and the subsequent lack of
repair has been considered responsible for carcinogenesis
[20]. Cancer cells can be subject to increased and persis-
tent oxidative stress due to elevated levels of intracellular
ROS generation. Reducing oxidative stress can therefore
suppress the proliferation of tumor cells and enhance
apoptosis [21]. Natural anti-oxidants have a wide range of
Figure 1 Structure of β-sitosterol isolated from A. curassavica. The 
compound was identified based on the following evidence: IR spec-
trum showed hydroxyl (3430 cm-1) and tris-substituted double-bond 
(1642 and 80.1 cm-1). The EI/MS mass spectrum showed m+ at m/z 
414, corresponding to the molecular formula (C29H50O) for β-sitosterol. 
The other characteristic peaks were at m/z 273 [m-sidechain]+ 255 [m-
side chain - H2O]+ 231 [m-side + +1chain-ring D], 213 [231-H2O] and 
300. The H-NMR spectrum showed 2 tertiary methyl groups at δ 0.68 
and 1.02, corresponding to H-18 and H-19. Three secondary methyls 
appeared at δ 0.92, 0.82 and 0.84, corresponding to H-21, H-26 and H-
27, respectively. (J = 6.5 Hz). H-29 appeared as triplet at δ 0.85 (J = 7.0 
Hz). The C-NMR spectrum indicated 29 carbon atoms, 10 primary, 10 
secondary and 3 tertiary carbon; 6 methyl groups being present. C-5 
and C-6 were olefinic carbon atoms appearing at δ 121.70 and 140.74.
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Figure 2 Anti-oxidant activity of β-sitosterol. The free radical scavenging ability of β-sitosterol was determined by DPPH and nitric oxide scaveng-
ing assays compared with ascorbic acid as a standard at various concentrations.
Baskar et al. BMC Complementary and Alternative Medicine 2010, 10:24
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Figure 3 Induction of apoptosis in COLO 320 DM. Human colon cancer cell lines (COLO 320 DM) cells were treated 120 or 240 μM β-sitosterol. The 
anti-proliferative effect is shown in (a), flow cytometric analysis for the determination of pro-apoptotic/apoptotic/necrotic cells is given in (b), and flu-
orescent staining of nuclei by Hoechst 33258 at 20× is seen in (c).
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biochemical activities, including inhibition of ROS gener-
ation, direct or indirect scavenging of free radicals, and
alteration of anti-oxidant potential [22]. Many anti-oxi-
dants have been used to inhibit apoptosis that is probably
mediated by oxidative stress. Many anti-oxidant sub-
stances have anti-cancer or anti-carcinogenic properties
[23]. A variety of cytotoxic/anti-cancer drugs induce
apoptosis in malignant cells in vitro [24]. Use of anti-neo-
plastic drugs needs to be based on their selective toxicity
to malignant cells, their advantage being this selectivity.
Ideally, this goal is to have with little or no effect on nor-
mal cells, the major problem faced in other cancer thera-
pies, many of which now combine a variety of modalities
to reduce this problem. Medicinal plants are mostly edi-
ble and do not exert toxic effects when taken regularly.
They exhibit anti-cancer potential by scavenging nitric
oxide radicals [25]. In vitro screening models provide
important preliminary data to select drugs with potential
anti-neoplastic properties for preclinical and clinical tri-
als.
β-sitosterol can scavenge the nitric oxide radicals gen-
erated in vitro by DPPH and NO scavenging assays by
donating their hydrogen atom to quench the free radicals,
indicating that β-sitosterol is a potential anti-oxidant.
Cytotoxicity screening models provide important prelim-
inary data to select compounds with potential antineo-
plastic properties for future work. A variety of cytotoxic
drugs can induce apoptosis of malignant cells in vitro
[24]. β-sitosterol showed cancer cell specific cytotoxic
effects by inhibiting proliferation of COLO 320 DM cells,
while showing little toxicity in VERO cells. β-sitosterol
has been reported to possess cytotoxic effects in breast
cancer and Bowes cell lines [8,26]. The present study
show β-sitosterol inhibits proliferation of colon cancer
cells with less toxicity towards normal cells in vitro.
β-catenin and PCNA are useful markers of proliferative
activity in colon carcinogenesis [27-29]. β-sitosterol
administration significantly decreased the expression of
β-catenin and PCNA (Figure 5). Oxidative stress aug-
ments Wnt-β catenin signalling machinery and PCNA
[30]. β-catenin plays a critical role as a component of the
cell adhesion complex and activated β-catenin signaling
favors cellular proliferation as well as exerting an anti-
apoptotic effect on a variety of cancers [31]. Positive cor-
relation between β-catenin accumulation and cell prolif-
eration in colon carcinoma has been reported [29].
Furthermore, excess β catenin promotes accumulation of
transcriptionally active p53 that may favor survival rather
than apoptosis [32]. While β-sitosterol posses anti-prolif-
erative and apoptotic potential in several cancer models
[33], the mechanism of action is not exactly known.
PCNA is a DNA polymerase δ auxiliary protein that
accumulates in the nuclei during late G1 and early S
phases. The fraction of PCNA-expressing cells is used as
an indicator of DNA synthesis and cellular proliferation
Figure 4 ROS Scavenging ability. β-sitosterol was treated with COLO 
320 DM cells for 24 h at 120 or 240 μM and the ROS scavenging ability 
determined using DCF staining and confocal microscopy. (A & B) COLO 
320 DM cells untreated, (C) COLO 320 DM cells treated with β-sitoster-
ol at 120 μM, (D) COLO 320 DM cells treated with β-sitosterol at 240 
μM.
 
Figure 5 Expression of β catenin (A) and PCNA (B) in COLO 320 
DM cells. Human colon cancer (COLO 320 DM) cells were treated with 
15, 30, 60, or 120 μM/ml β-sitosterol for 24 h and 50 μg of extracted 
protein were loaded.
A 
B Baskar et al. BMC Complementary and Alternative Medicine 2010, 10:24
http://www.biomedcentral.com/1472-6882/10/24
Page 8 of 10
[34]. Oxidative stress in cancer cells is maintained at high
levels that promote cellular proliferation [35]. Treatment
with β-sitosterol markedly decreased the proliferative
index as revealed by the down regulation of β-catenin and
PCNA expression in COLO 320 DM cells. Antioxidants
have been reported to suppress the β-catenin mutation in
hepatocellular carcinomas in rats [36]. Hence this ability
of β-sitosterol to suppress the levels of β-catenin, PCNA
and its target genes might be attributed to its antioxidant
property. β-sitosterol suppresses the altered β-catenin
and PCNA mutation in COLO 320 DM cells and pushes
the cells towards apoptosis by their ability to scavenge the
radicals produced in COLO 320 DM cells.
ACF are putative preneoplastic lesions in colon car-
cinogenesis and considered as surrogate precursors
lesions of colorectal cancer. ACFs are readily discernible
morphological changes within the colonic mucosa of
rodents that may contribute to the stepwise progression
of colon cancer [37]. Natural compounds that inhibit
ACF induced by colon carcinogens are protective against
colon cancer in rodents [38]. β-sitosterol supplementa-
tion decreased the number of ACFs in DMH-induced
animals in a dose-dependent manner. PCNA and β-
catenin levels are increased in animals treated with DMH
and treatment with an anti-cancer compound reduces the
incidence of ACFs in DMH-induced animals [31]. The
levels of β-catenin and PCNA are directly proportionate
to ACF development in colon carcinogenesis. The anti-
carcinogenic property of β-sitosterol in DMH-induced
colon carcinogenesis is due to its anti-oxidant properties.
The ability to suppress the β-catenin mutation in DMH-
induced animals in short-term colon carcinogenesis sug-
gests that β-sitosterol may have a chemopreventive effect
on the development of tumors upon longer treatment
protocols. β-sitosterol supplementation at 20 mg/kg b.w.
significantly reduced the incidence of ACF in carcinogen
treated animals by 73.6%. Hence from both our in vitro
and in vivo results it is evident that β-sitosterol exhibits
chemopreventive potential in DMH induced experimen-
tal carcinogenesis by inhibiting levels of β-catenin and
PCNA accumulation in colon cancer. The present study
confirms the anti-carcinogenic potential of β-sitosterol
and the effective dose to be 20 mg/kg b.w. in 1, 2-dimeth-
ylhydrazine induced colon carcinogenesis
Figure 6 Topographical view of ACF. Topographical views of (A & B) 
normal crypt (40×), (C) ACF (arrows) with multiple crypts in the colon 
from a rat treated with DMH (40×), (D) ACF (arrow) with 2 and 3 crypts 
in the colon from a rat treated with DMH+ β-sitosterol (5 mg/kg), (E) 
ACF (arrow) with multiple 2 crypts in the colon from a rat treated with 
DMH+ β-sitosterol (10 mg/kg), and (F) ACF (arrow) with single 2 crypts 
in the colon from a rat treated with DMH+ β-sitosterol (20 mg/kg).
Table 1: Effect of β-sitosterol on development of ACF induced by DMH
ACF formation in rat colon
Groups Total no. of ACF No. of AC Crypt multiplicity 
(AC/ACF)
% of ACF inhibition
DMH 52 ± 5.23a 151 ± 12.31a 2.9 ± 0.31a -
DMH + β-sitosterol (5 
mg/Kg)
47 ± 4.68a 126 ± 10.36b 2.6 ± 0.25b 38.2
DMH + β-sitosterol (10 
mg/Kg)
38 ± 4.12b 92 ± 10.21c 2.4 ± 0.18c 52.8
DMH + β-sitosterol (20 
mg/Kg)
29 ± 3.14c 54 ± 8.94d 1.8 ± 0.16d 73.6
Each value is mean ± SD for 6 replicates in each group. Values carrying different letters in a row differ significantly at p < 0.05 by DMRT.Baskar et al. BMC Complementary and Alternative Medicine 2010, 10:24
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Conclusions
The anticarcinogenic property of β-sitosterol in DMH-
induced colon carcinogenesis is due to its antioxidant
property and its ability to suppress the altered β-catenin
and PCNA expression in colonic mucosa of DMH-
treated rats in short-term colon carcinogenesis. Hence
the study suggests that β-sitosterol exerts a chemopre-
ventive effect in DMH-induced experimental carcinogen-
esis, indicating its potential as an anticancer drug. The
effective dose for long-term studies will be 10-20 mg/kg
b.w. in experimentally induced colon carcinogenesis.
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